Business
SBC Medical Group Holdings Announces First Quarter 2026 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)-- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization
About this update from Sbc Medical Group Holdings Incorporated
[{"type":"text","content":" IRVINE, Calif.--(BUSINESS WIRE)--\nSBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026.\n\n\nFirst Quarter 2026 Highlights\n\n\n\nTotal revenues were $43 million, representing a 9% year-over-year decrease.\n\n\n\nNet income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net income margin was 26% for the first quarter of 2026, representing a year-over-year decrease of 19 percentage points.\n\n\n\nEarnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.11 for the three months ended March 31, 2026, representing a 48% year-over-year decrease.\n\n\n\nEBITDA1, which is calculated by adding depreciation and amortization expense to income from operations was $18 million, representing a 26% year-over-year decrease. EBITDA margin1 was 43% for the first quarter of 2026, representing a year-over-year decrease of 10 percentage points.\n\n\n\nReturn on equity2, which is defined as net income attributable to the Company divided by the average shareholders' equity as of March 31, 2026, was 18% representing a year-over-year decrease of 23 percentage points.\n\n\n\nNumber of franchise locations3 was 284 as of March 31, 2026, representing an increase of 33 locations from March 31, 2025.\n\n\n\nNumber of customers4 in the last twelve months ended March 31, 2026, was 6.76 million, representing a 10% year-over-year increase.\n\n\n\nRepeat rate for customers5 who visited franchisee’s clinics twice or more was 72%.\n\n\n\nYoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical, said, “For the first quarter of fiscal year 2026, SBC Medical reported revenue of $43 million, representing a 9% year-over-year decline. This decrease was primarily attributable to a strategic structural reform implemented in April 2025, involving a revision of the franchise fee structure. Excluding this structural change, the performance of our core business remained solid. In terms of profitability, our net income margin was 26%, and our EBITDA margin remained at a high level of 43%.\n\n\...